We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMEO
5076
DELISTED
Vimeo
VMEO
$4K ﹤0.01%
1,211
-21,338
-95% -$82.5K
VNDA icon
5077
Vanda Pharmaceuticals
VNDA
$304M
$4K ﹤0.01%
543
-16,642
-97% -$162K
YARW
5078
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$4K ﹤0.01%
29
-1
-3% -$200
WKSP icon
5079
Worksport
WKSP
$10.4M
$4K ﹤0.01%
380
+180
+90% +$2.93K
WTBA icon
5080
West Bancorporation
WTBA
$511M
$4K ﹤0.01%
167
-2,626
-94% -$60.4K
WYY icon
5081
WidePoint Corp
WYY
$115M
$4K ﹤0.01%
2,349
-737
-24% -$1.62K
XGN icon
5082
Exagen
XGN
$159M
$4K ﹤0.01%
1,476
+1,441
+4,117% +$3.7K
XNTK icon
5083
State Street SPDR NYSE Technology ETF
XNTK
$2.27B
$4K ﹤0.01%
40
-2,829
-99% -$280K
ZDGE icon
5084
Zedge
ZDGE
$38.9M
$4K ﹤0.01%
2,340
-2,917
-55% -$6.31K
ZVIA icon
5085
Zevia
ZVIA
$101M
$4K ﹤0.01%
1,035
+686
+197% +$2.83K
AIFC
5086
AI Financial Corp
AIFC
$58.9M
$4K ﹤0.01%
3,126
+2,935
+1,537% +$5.75K
DJT icon
5087
Trump Media & Technology Group
DJT
$2.31B
$4K ﹤0.01%
297
-1,512
-84% -$29.5K
AIFF
5088
Firefly Neuroscience
AIFF
$18.1M
$4K ﹤0.01%
262
-40
-13% -$931
HURA
5089
TuHURA Biosciences
HURA
$146M
$4K ﹤0.01%
16
-1
-6% -$222
IVF
5090
INVO Fertility Inc
IVF
$1.73M
0
MTVA
5091
MetaVia Inc
MTVA
$7.54M
$4K ﹤0.01%
61
+59
+2,950% +$25.3K
CIRC
5092
Circle8 Group
CIRC
$61.2M
$4K ﹤0.01%
315
-2
-0.6% -$39
NXXT
5093
NextNRG Inc
NXXT
$54.2M
$4K ﹤0.01%
714
-69
-9% -$691
EVBN
5094
DELISTED
Evans Bancorp Inc
EVBN
$4K ﹤0.01%
+99
New +$3.71K
FBMS
5095
DELISTED
The First Bancshares, Inc.
FBMS
$4K ﹤0.01%
119
-3,604
-97% -$117K
BEST
5096
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$4K ﹤0.01%
2,009
-147
-7% -$368
BRKHU
5097
DELISTED
BurTech Acquisition Corp. Unit
BRKHU
$4K ﹤0.01%
386
-300
-44% -$3.04K
GVP
5098
DELISTED
GSE Systems, Inc.
GVP
$4K ﹤0.01%
596
+198
+50% +$1.49K
VSACU
5099
DELISTED
Vision Sensing Acquisition Corp. Unit
VSACU
$4K ﹤0.01%
359
AUGX
5100
DELISTED
Augmedix, Inc. Common Stock
AUGX
$4K ﹤0.01%
2,850
-3,608
-56% -$4.6K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.